Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant
Clinical trial NCT02781571 · COMPLETED
Trial details
- NCT number
- NCT02781571
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-27
- Primary completion
- 2017-07-28
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.